| Controlled Human Infection Model Challenge/Rechallenge (NCT04992520) | PATH | 2022-04-26 |
| Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years (NCT05156528) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2021-12-11 |
| Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery (NCT03854929) | Oxford University Clinical Research Unit, Vietnam | 2019-12-11 |
| A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants (NCT04056117) | LimmaTech Biologics AG | 2019-09-02 |
| SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers (NCT02797236) | Institut Pasteur | 2016-09-01 |
| Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a (NCT02646371) | LimmaTech Biologics AG | 2015-12-01 |
| Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) (NCT02445963) | U.S. Army Medical Research and Development Command | 2015-10-01 |
| Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a (NCT02388009) | LimmaTech Biologics AG | 2015-02-01 |
| Diagnosis of Neglected Tropical Diseases Among Patients With Persistent Digestive Disorders (NCT02105714) | Swiss Tropical & Public Health Institute | 2014-07-01 |
| Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults (NCT02034500) | GSK Vaccines Institute For Global Health S.r.l. | 2014-03-01 |
| A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults. (NCT02017899) | GSK Vaccines Institute For Global Health S.r.l. | 2014-02-01 |
| Shigella Sonnei OSPC-rDT Conjugate Vaccine (NCT01399424) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2011-07-16 |
| Shigella Sonnel O-SPC/rBRU Conjugate Vaccine (NCT01369927) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2011-05-15 |
| Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults (NCT01509846) | PATH | 2011-03-01 |
| Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella (NCT01069471) | GlycoVaxyn AG | 2010-02-01 |
| Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection (NCT00485134) | U.S. Army Medical Research and Development Command | 2007-05-01 |
| Therapeutic Induction of Endogenous Antibiotics (NCT00800930) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2005-01-01 |
| Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel (NCT00368316) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2003-01-01 |